You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use

https://doi.org/10.1136/ejhpharm-2023-003795

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors Conceptualisation, RV and NY; investigation, IB; resources, NY and IB; writing—original draft preparation, RV and IB; writing—review and editing, NY and ABE; supervision, ABE.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.